My research program is dedicated to advancing clinical-translational studies of neurodegenerative diseases, including Parkinson’s disease (PD), frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease (AD). By integrating neuroimaging, multi-omics, and AI-driven analytics, I aim to uncover the biological mechanisms underlying these disorders and develop robust biomarkers for early diagnosis, disease subtyping, and therapeutic development.
My research program is dedicated to advancing clinical-translational studies of neurodegenerative diseases, including Parkinson’s disease (PD), frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease (AD). By integrating neuroimaging, multi-omics, and AI-driven analytics, I aim to uncover the biological mechanisms underlying these disorders and develop robust biomarkers for early diagnosis, disease subtyping, and therapeutic development.